Pacemaker implant site infection caused by atypical mycobacteria.
Verghese
S
S
Department of Microbiology, Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai.
Mullaseri
A
A
Padmaja
P
P
Subhadra
A C
AC
Cherian
K M
KM
D000368:Aged; D000900:Anti-Bacterial Agents; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D009170:Nontuberculous Mycobacteria / Q000302:isolation & purification*; D010138:Pacemaker, Artificial / Q000009:adverse effects*; D012086:Reoperation; D013530:Surgical Wound Infection / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*
D000900:Anti-Bacterial Agents